About Waters ACQUITY UPC2 System
UPC2 Technology is based on the principles of UltraPerformance Convergence Chromatography which employs compressed carbon dioxide as the primary mobile phase constituent. The instrument is based on the robust, reliable low-dispersion design of the Waters ACQUITY UPLC® platform perfected for use with sub-two-micron particle technology.
The technique is suitable for a diverse range of compounds including most organic-soluble compounds, most salts of organic acids and bases, small lipophilic peptides and non-polar solutes. It is ideal for structurally similar compounds including chiral entities, diastereomers, enantiomers, positional isomers and structural analogs. Essentially any compound soluble in an organic solvent is a candidate for convergence chromatography. The technique is also compatible with many popular detection modes including the full range of Waters mass spectrometers.
Laboratories purchasing the ACQUITY UPC2 System are finding it to be ideally suited for chiral separations and a welcome replacement for solvent-hungry normal phase LC.
Helping Laboratories Meet Their Sustainability Objectives.
Laboratory-dependent organizations can consume large amounts of organic solvents that are expensive to purchase and can be twice as expensive to dispose of. Many of these organizations have set aggressive sustainability goals for themselves and are investigating the potential of Waters UPC2 Technology to help meet them and, in turn, save hundreds of thousands of dollars over time.
For these reasons, interest in the t
|SOURCE Waters Corporation|
Copyright©2012 PR Newswire.
All rights reserved